ElizabethMarionJaffeeMD

Gastrointestinal Cancer

Professor of Oncology and Professor of Pathology, Johns Hopkins University School of Medicine; The Dana and Albert "Cubby" Broccoli Professor of Oncology; Co-Director, Skip Viragh Center for Pancreas Cancer; Co-Director, Gastrointestinal Cancers Program; Co-Director of the Cancer Immunology Program and the Immunology and Hematopoiesis Division

Join to view full profile

Dr. Jaffee is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Jaffee's full profile

Already have an account?

Office
600 N Wolfe St
Baltimore, MD 21287
Phone+1 410-955-8964

Education & Training

Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 1989 - 1992
UPMC Medical EducationInternship, Internal Medicine, 1985 - 1986
New York Medical CollegeClass of 1985

Certifications & Licensure

MD State Medical License 1989 - 2026
PA State Medical License 1986 - 1990
American Board of Internal Medicine Internal Medicine

Clinical Trials

Palliative Stereotactic Radiation for Pancreatic or Periampullary Adenocarcinoma Start of enrollment: 2013 Jan 01
COMPLETED
PHASE2

Publications & Presentations

PubMed

Anti-CTLA4 therapy leads to early expansion of a peripheral Th17 population and induction of Th1 cytokines.
Mari Nakazawa, Soren Charmsaz, Elsa Hallab, Mike Fang, Chester Kao
Cancer Immunology Research. 2025-03-27
1 citations
Phase 1 Study of Adjuvant Allogeneic Granulocyte-Macrophage Colony-Stimulating Factor-Transduced Pancreatic Tumor Cell Vaccine, Low-Dose Cyclophosphamide, and Stereota...
Colin S Hill, Rose Parkinson, Elizabeth M Jaffee, Elizabeth Sugar, Lei Zheng
International Journal of Radiation Oncology, Biology, Physics. 2025-03-15
Author Correction: Stromal changes in the aged lung induce an emergence from melanoma dormancy.
Mitchell E Fane, Yash Chhabra, Gretchen M Alicea, Devon A Maranto, Stephen M Douglass
Nature. 2025-02-01

Journal Articles

Development of Tumor Mutation Burden as an Immunotherapy Biomarker: Utility for the Oncology Clinic
Mark Yarchoan, Elizabeth Jaffee, Annals of Oncology

Press Mentions

Drug Combination Prompts Immune Response in Some Resistant Pancreatic CancersNovember 15th, 2024
Drug Combination Boosts Immune Response in Resistant Pancreatic CancersNovember 15th, 2024
Drug Combination Prompts Immune Response in Some Resistant Pancreatic CancersNovember 14th, 2024
Join now to see all

Grant Support

Targeting HMGA1 Tumor-Stromal Networks in Pancreatic CarcinogenesisJOHNS HOPKINS UNIVERSITY2024–2029
Transforming Human Pancreatic Cancer Into An Immunologic DiseaseJOHNS HOPKINS UNIVERSITY2021–2026
Targeting the Immunosuppressive Tumor Microenvironment of Pancreatic Cancer with a Neoadjuvant Platform Clinical TrialJOHNS HOPKINS UNIVERSITY2015–2026